Theraclone has flu therapy ready for human trials
Date: Wednesday, September 21, 2011, 2:47pm PDT
Theraclone Sciences just announced their influenza A-fighting antibody therapy
Valerie Bauman
Staff Writer
Seattle-based Theraclone Sciences Inc. announced Sept. 21 that its research into influenza-fighting antibodies is entering the next, critical phase: human clinical trials.
Theraclone?s new kind of flu therapy would treat the illness, instead of focusing on preventing it, as current vaccines do.
And it could treat multiple mutations of the virus, instead of having to be adapted each year to new strains.
?We hope this is the one that can be used every season and potentially for a pandemic,? said Dr. Leni Ramos, Theraclone?s chief medical officer....
